Takeda Pharmaceutical Company Limited Increase Decrease Through Change In Equity Of Subsidiaries
Takeda Pharmaceutical Company Limited (TAK) reported Increase Decrease Through Change In Equity Of Subsidiaries of JPY 18.00 million for the 12-month period ending 2024-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughChangeInEquityOfSubsidiaries · last filed 2025-06-25
| Period end | Increase Decrease Through Change In Equity Of Subsidiaries 12 month |
|---|---|
| 2024-03-31 | 18.00M JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | -5.95B JPY 20-F · filed 2024-06-26 |
| 2019-03-31 | -17.64B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | -32.75B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | -5.49B JPY 20-F · filed 2019-06-27 |